Holoclara Inc.
PrivateLast Round
Series A
Jun 27, 2024
Total Funding Raised
$16.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Holoclara Inc. is a biotechnology company that develops orally available, symbiont-derived immunotherapies for autoimmune and allergic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Holoclara Inc. Comparables
Compare Holoclara Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siolta Therapeutics | 80% | |
| Revolo Biotherapeutics | 78% | |
| Ditto Biosciences | 78% |
Holoclara Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 27, 2024 | ||||
| Grant | Apr 15, 2023 | ||||
| Seed | May 9, 2017 |
Holoclara Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A |
| NIH RADx | Grant |
| Freeflow Ventures | Series A |
| Kairos Ventures | Seed |
| BOLD Capital Partners | Series A |
| SV Latam Capital | Series A |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 56% MoM.
- Jun 27, 2024
$16M round led by BOLD Capital Partners.
Holoclara Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Holoclara Inc.'s valuation, stock price, and market status.
Is Holoclara Inc. a public or private company?
Holoclara Inc. is a private company.
What is the current stock price of Holoclara Inc.?
Holoclara Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Holoclara Inc. worth (valuation)?
Valuation information for Holoclara Inc. is not publicly available.
Can I buy Holoclara Inc. stock?
Holoclara Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Holoclara Inc.'s last funding round?
Holoclara Inc.'s most recent funding round was Series A on June 27, 2024.
Who are the main investors in Holoclara Inc.?
Key investors in Holoclara Inc. include BOLD Capital Partners.
Will Holoclara Inc. IPO soon?
No public IPO plans have been announced for Holoclara Inc..
How can I track Holoclara Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Holoclara Inc.'s secondary market activity and sign up for updates.